LEMAITRE VASCULAR, INC. (LMAT) Free cash flow 2016–2025
LEMAITRE VASCULAR, INC. (LMAT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$74.5MFY2025 · since FY2016: $14.1M → $74.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $74.5M | +100.4% |
| FY2024 | $37.2M | +26.0% |
| FY2023 | $29.5M | +33.1% |
| FY2022 | $22.1M | -26.7% |
| FY2021 | $30.2M | -5.0% |
| FY2020 | $31.8M | +205.4% |
| FY2019 | $10.4M | -36.7% |
| FY2018 | $16.5M | +0.0% |
| FY2017 | $16.5M | +17.0% |
| FY2016 | $14.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More LMAT financial trends
LMAT RevenueLMAT Net incomeLMAT Net marginLMAT Gross profitLMAT Gross marginLMAT Operating incomeLMAT Operating marginLMAT Operating cash flowLMAT Capital expendituresLMAT Return on equityLMAT Stock buybacksLMAT Dividends paidLMAT Total assetsLMAT Total liabilitiesLMAT Shareholders’ equityLMAT overview →